Biotechnology Issues for Developing Countries

Electronic Journal of Biotechnology ISSN: 0717-3458 Vol. 10 No. 2, Issue of April 15, 2007
© 2007 by Pontificia Universidad Católica de Valparaíso -- Chile Received October 13, 2006 / Accepted December 18, 2006
DOI: 10.2225/vol10-issue2-fulltext-12
BIOTECHNOLOGY ISSUES FOR DEVELOPING COUNTRIES

Strategic approaches to informing the public about biotechnology in Latin America

Patricia L. Traynor
New Agritech Strategies
P.O.Box 10173
Blacksburg VA 24062
Virginia, USA
Tel: 540 552 5374
Fax: 540 961 2629
E-mail: traynor@texnet.net

Marta Adonis
Cellular and Molecular Biology Program
Institute of Biomedical Sciences
Faculty of Medicine, University of Chile
Independencia 1027, Santiago, Chile
Tel: 562 978 6061
Fax: 562 7356373
E-mail: lgil@med.uchile.cl

Lionel Gil*
Cellular and Molecular Biology Program
Institute of Biomedical Sciences
Faculty of Medicine, University of Chile
Independencia 1027, Santiago, Chile
Tel: 562 978 6068/6413
Fax: 562 7356373
E-mail: lgil@med.uchile.cl

*Corresponding author

Financial support: This work has been supported by OAS Project Number AE-192-4: Capacity Building for the Safe and Sustainable use of Biotechnology, within the Framework of the Biosafety Protocol. 

Keywords: biotechnology, GMOs, public perception.

Abstract   Full Text

The benefits of today’s biotechnology products are not evident to consumers. The public will accept biotechnology only when individuals decide for themselves that biotec products will contribute to their personal well-being. To make such a decision, people will need greater awareness and understanding of how biotechnology will affect the environment, human health, local and national economies, and the well-being of society. A low level of awareness and understanding about biotechnology is characteristic of Latin America and the Caribbean countries, as elsewhere, efforts to remedy poor public perception often seem inadequate and do not reflect a well-designed strategy.

In order to improve the understanding of the biotechnology and their human applications, a strategic plan for public communications is required. Specific objectives for this initiative may include: (1) to make evident to decision makers that modern biotechnology can be an effective tool for increasing agricultural productivity, and thereby economic growth, without imposing unacceptable risk to the environment or human and animal health; (2) to enable members of the public to make informed decisions about appropriate uses of biotechnology by providing accurate information about benefits, risks and impacts; or (3) to incorporate modern biotechnology into science curricula for secondary schools, university and college students, and agriculture extension officers.

A variety of specialized expertise, including communication specialists, technical writers, graphic artists and illustrators to design information materials and conduct training is needed to implement this. Ideally, members bring expertise in biotechnology and biosafety, public communications and project management. The plan will need to identify scientists and technical experts who can provide expertise in science writing for general audiences, advertising, graphic arts, public opinion polling and media communications. These people can provide basic information about the techniques of modern biotechnology; the products now available and those being developed; what is known about the nature, probability and consequences of potential risks. Governments, industry, universities and media must play an important role to improve public perception about biotechnology, this is a requirement to develop biotechnology in the Region.

Supported by UNESCO / MIRCEN network